NovaBay Pharmaceuticals, Inc. Accounts Payable Turnover

Accounts Payable Turnover of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Payable Turnover growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Accounts Payable Turnover for 2021 was 4.12 (a -67.14% decrease from previous year)
  • Annual Accounts Payable Turnover for 2020 was 12.54 (a 218.28% increase from previous year)
  • Annual Accounts Payable Turnover for 2019 was 3.94 (a 33.33% increase from previous year)
  • Twelve month Accounts Payable Turnover ending September 30, 2022 was 4.3 (a -43.26% decrease compared to previous quarter)
  • Twelve month trailing Accounts Payable Turnover increased by 4.39% year-over-year
Trailing Accounts Payable Turnover for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
4.3 7.58 2.87 4.12
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Payable Turnover of NovaBay Pharmaceuticals, Inc.

Most recent Accounts Payable Turnoverof NBY including historical data for past 10 years.

Interactive Chart of Accounts Payable Turnover of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Accounts Payable Turnover for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 4.12
2020 12.54
2019 3.94
2018 2.96
2017 6.05
2016 1.68
2015 0.58
2014 0.27
2013 0.15
2012 0.02
2011 0.0

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology